VIMPAT 200 MG COM REV CT BL AL PLAS TRANS X 28
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1236100810119 -
GGREM
525214080020002 -
Código de barras
5413787012794
O que a fonte publica
- Detentor do registro
- UCB BIOPHARMA LTDA.
- Princípios ativos
- LACOSAMIDA
- Embalagem
- 200 MG COM REV CT BL AL PLAS TRANS X 28
- Regime de dispensação
- Tarja Vermelha sob restrição
- Tipo de produto
- Novo
- Classe terapêutica
- N3A - ANTIEPILÉPTICOS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "VIMPAT 200 MG COM REV CT BL AL PLAS TRANS X 28",
"holder": "UCB BIOPHARMA LTDA.",
"stripe": "Tarja Vermelha sob restrição",
"barcodes": [
"5413787012794"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "525214080020002",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "64.711.500/0001-14",
"priceRegime": "Regulado",
"productName": "VIMPAT",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "200 MG COM REV CT BL AL PLAS TRANS X 28",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha sob restrição",
"factoryPrices": {
"icms-0": "459.65",
"icms-12": "522.33",
"icms-17": "553.80",
"icms-18": "560.55",
"icms-19": "567.47",
"icms-20": "574.56",
"icms-21": "581.84",
"icms-22": "589.29",
"icms-23": "596.95",
"icms-17.5": "557.15",
"icms-19.5": "570.99",
"icms-20.5": "578.18",
"icms-22.5": "593.10",
"icms-12-alc": "466.37",
"icms-17-alc": "494.46",
"icms-18-alc": "500.49",
"icms-19-alc": "506.67",
"icms-20-alc": "513.00",
"icms-21-alc": "519.50",
"icms-22-alc": "526.16",
"icms-23-alc": "532.99",
"withoutTaxes": "410.40",
"icms-17.5-alc": "497.46",
"icms-19.5-alc": "509.82",
"icms-20.5-alc": "516.23",
"icms-22.5-alc": "529.55"
},
"pisCofinsList": "Negativa",
"substanceText": "LACOSAMIDA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "616.60",
"icms-12": "700.69",
"icms-17": "742.90",
"icms-18": "751.96",
"icms-19": "761.24",
"icms-20": "770.75",
"icms-21": "780.52",
"icms-22": "790.51",
"icms-23": "800.79",
"icms-17.5": "747.40",
"icms-19.5": "765.96",
"icms-20.5": "775.61",
"icms-22.5": "795.62",
"icms-12-alc": "644.73",
"icms-17-alc": "683.56",
"icms-18-alc": "691.90",
"icms-19-alc": "700.44",
"icms-20-alc": "709.19",
"icms-21-alc": "718.18",
"icms-22-alc": "727.39",
"icms-23-alc": "736.83",
"withoutTaxes": "567.36",
"icms-17.5-alc": "687.71",
"icms-19.5-alc": "704.80",
"icms-20.5-alc": "713.66",
"icms-22.5-alc": "732.07"
},
"invalidBarcodes": [],
"activeSubstances": [
"LACOSAMIDA"
],
"therapeuticClass": "N3A - ANTIEPILÉPTICOS",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1236100810119",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "N3A",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:525214080020002"